Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan

Journal of Oral Pathology and Medicine

Volumn 28, Issue 4, 1999, Pages 165-169

  Kuo, Mark Yen Ping ^a   Lin, Chiao Ying ^a   Hahn, Liang Jiunn ^a   Cheng, Shih Jung ^a   Chiang, Chun Pin ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Areca quid chewing; Cyclin D1; Oral squamous cell carcinoma; Prognosis

Indexed keywords

EID: 0006117046     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb02017.x     Document Type: Article

References (30)

1. MOTOKURA T, ARNOLD A. Cyclins and oncogenesis. Biochim Biophy Acta 1993; 1155: 63-78.
2. SHERR CJ. G1 phase progression: cycling on cue. Cell 1994; 79:551-5.
3. HUNTER T, PINES J. Cyclins and cancer. II. Cyclin D and cdk inhibitors come of age. Cell 1994; 79:573-82.
4. BALDIN V, LUKAS J, MARCOTE MJ, et al. Cyclin D1 is a protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812-21.
5. JIANG W, KAHN SM, ZHOU P, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993; 8:3447-57.
6. QUELLE DE, ASHMUN RA, SHURTLEFF SA, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 1559-71.
7. LOVEC H, SEWING A, LUCIBELLO F, MULLER R, MOROY T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 1994; 9:323-6.
8. JIANG W, ZHANG YJ, KAHN SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993; 90:9026-30.
9. ZHANG YJ, JIANG W, CHEN CJ. et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993; 196:1010-6.
10. GILLETT C, FANTL V, SMITH R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54:1812-7.
11. BARTKOVA J, LUKAS J, MULLER H, STRAUSS M, GUSTERSON B, BARTER J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995; 55:949-56.
12. BARTKOVA J, LUKAS J, MULLER H, STRAUSS M, BARTEK J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10:775-8.
13. BERENSON JR, YANG J, MICKEL RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 1989; 4:111-6.
14. CALLENDER T, EL-NAGGAR AK, LEE MS, et al. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994; 74:152-8.
15. MULLER D, MILLON R, LIDEREAU R, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol 1994; 30: 113-20.
16. VOLLING P, JUNGEHULSING M, JUCKER M, STUTZER H, DIEHL V, TESCH H, Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck. Eur J Cancer 1993; 29:383-9.
17. KOTELNIKOV VM, COON JS, MUNDLE S. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res 1997; 3: 95-101.
18. JARES P, FERNANDEZ PL, CAMPO E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994; 54:4813-7.
19. MICHALIDES R, VAN VEELEN N, HART A, LOFTUS B, WIENTJENS E, BALM A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995; 55: 975-8.
20. IARC. Betel-quid and areca-nut chewing. Lyon: International Agency for Research on Cancer, Monographs 1986; 37: 141-202.
21. KO YC, CHIANG TA, CHANG SJ, HSIEH SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 1992; 21:261-4.
22. KWAN HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel quid chewing: a preliminary report. J Formos Med Assoc 1976; 75: 497-505.
23. KUO MYP, JENG JH, CHIANG CP, HAHN LJ. Mutation of ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1994; 23:70-4.
24. KUO MYP, CHANG HH, HAHN LJ, WANG JT, CHIANG CP. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 1995; 24:255-60.
25. FILMUS J, ROBLES AI, SHI W, WONG MJ, COLOMBO LL, CONTI CJ. Induction of cyclin D1 overexpression by activated ras. Oncogene 1994; 9:3627-33.
26. HERMANEK P, SOBIN LH. eds. TNM classification of malignant tumours. 4th edn. Heidelberg: Springer-Verlag, 1992; 1-34.
27. ROBLES AL, CONTI CJ. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis 1995; 16:781-6.
28. GIMENEZ-CONTI IB, COLLET AM, LANFRANCHI H, et al. p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas. Cancer 1996; 78: 17-23.
29. SCHUURING E, VERHOEVEN E, VAN TINTEREN H, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992; 52:5229-34.
30. MCINTOSH GG, ANDERSON JJ, MILTON I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11:885-91.